ARCHIVES

Foreeman, Brinker, Jako Appointed To Cancer Panel

This article is from The Cancer Letter archive.

Vol. 17 No. 16 | April 19, 1991

Download PDF Visit The Full Archive

Related Articles

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

Flint Chop Shows That Successful Community Program Can Be Developed And Operated Without NCI Funding

January 21, 1983

NCI Predicts 42 Percent Increase In Number of Senior Survivors

October 28, 2011

Arbuck Leaves NCI to Guide BMS Oncology Pipeline.

September 7, 2001

Lung Cancer Size May Not Indicate Severity Of Disease

March 29, 2002